NanoCarrier Co Ltd (4571.T)
21 Nov 2017
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|62||1996||President, Chief Executive Officer, Representative Director|
|60||2011||Chief Financial Officer, Director of Administration, Manager of President's Office, Board of Director|
|57||2014||Chief Operating Officer, Director of Business Development, Director|
|59||2014||Chief Scientific Officer, Director|
- BRIEF-VBL Therapeutics and Nanocarrier signs agreement for VB-111 in Japan
- BRIEF-Nanocarrier signs exclusive agreement with VBL Therapeutics for VB-111 in Japan
- BRIEF-NanoCarrier and JCR conclude collaborative research agreement for drug delivery to the brain for nucleic acid medicines
- BRIEF-NanoCarrier says orphan drug designation of NC-6004 by the U.S. FDA
- BRIEF-NanoCarrier receives orphan drug designation from FDA